| 0 |
CORNEAL TOXICITY |
1 |
0.0090 |
| 1 |
INSTILLATION SITE DISCOMFORT |
1 |
0.0075 |
| 2 |
ACANTHOSIS |
2 |
0.0061 |
| 3 |
KERATOCONJUNCTIVITIS SICCA |
2 |
0.0054 |
| 4 |
CHOROIDAL HAEMORRHAGE |
1 |
0.0052 |
| 5 |
GRAFT THROMBOSIS |
1 |
0.0038 |
| 6 |
IRIDOCYCLITIS |
7 |
0.0022 |
| 7 |
BACTERIURIA |
1 |
0.0018 |
| 8 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
1 |
0.0014 |
| 9 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 10 |
VITREOUS OPACITIES |
1 |
0.0012 |
| 11 |
TOXIC ANTERIOR SEGMENT SYNDROME |
1 |
0.0009 |
| 12 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
7 |
0.0009 |
| 13 |
SICK SINUS SYNDROME |
1 |
0.0009 |
| 14 |
EYELID DISORDER |
2 |
0.0009 |
| 15 |
INSTILLATION SITE IRRITATION |
1 |
0.0008 |
| 16 |
DYSPLASIA |
1 |
0.0008 |
| 17 |
CAROTID ARTERY DISEASE |
1 |
0.0008 |
| 18 |
PRODUCT DEPOSIT |
1 |
0.0006 |
| 19 |
MUSCLE CRAMP |
1 |
0.0006 |
| 20 |
PRODUCT DELIVERY MECHANISM ISSUE |
3 |
0.0006 |
| 21 |
EYELID PAIN |
1 |
0.0005 |
| 22 |
EXOPHTHALMOS |
1 |
0.0005 |
| 23 |
CALCINOSIS |
1 |
0.0004 |
| 24 |
INFREQUENT BOWEL MOVEMENTS |
1 |
0.0004 |
| 25 |
MEDICATION RESIDUE |
1 |
0.0004 |
| 26 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 27 |
CHONDROPATHY |
1 |
0.0004 |
| 28 |
TENOSYNOVITIS |
1 |
0.0004 |
| 29 |
PNEUMATOSIS INTESTINALIS |
1 |
0.0004 |
| 30 |
LIP PAIN |
1 |
0.0003 |
| 31 |
EYELID MARGIN CRUSTING |
1 |
0.0003 |
| 32 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 33 |
THERAPEUTIC AGENT TOXICITY |
1 |
0.0003 |
| 34 |
ANXIETY DISORDER |
1 |
0.0003 |
| 35 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 36 |
ROSACEA |
1 |
0.0002 |
| 37 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 38 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 39 |
STOMACH DISCOMFORT |
1 |
0.0002 |
| 40 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 41 |
SWELLING OF EYELID |
1 |
0.0002 |
| 42 |
INTRAOCULAR PRESSURE INCREASED |
2 |
0.0002 |
| 43 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 44 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 45 |
ONYCHOCLASIS |
1 |
0.0001 |
| 46 |
LYMPHOEDEMA |
1 |
0.0001 |
| 47 |
DIALYSIS |
2 |
0.0001 |
| 48 |
BRONCHOSPASM |
2 |
0.0001 |
| 49 |
EYE IRRITATION |
8 |
0.0001 |
| 50 |
ARTHROPOD BITE |
1 |
0.0001 |
| 51 |
BLOOD DISORDER |
1 |
0.0001 |
| 52 |
MUSCLE STRAIN |
1 |
0.0001 |
| 53 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 54 |
GROIN PAIN |
1 |
0.0001 |
| 55 |
LUNG INFILTRATION |
1 |
0.0001 |
| 56 |
LIP DRY |
1 |
0.0001 |
| 57 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 58 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 59 |
OCULAR HYPERAEMIA |
5 |
0.0001 |
| 60 |
EYE INFLAMMATION |
1 |
0.0001 |
| 61 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 62 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 63 |
TOOTH ABSCESS |
1 |
0.0001 |
| 64 |
SKIN INFECTION |
1 |
0.0001 |
| 65 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 66 |
EYE PAIN |
5 |
0.0001 |
| 67 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 68 |
TENDON RUPTURE |
1 |
0.0001 |
| 69 |
EYE SWELLING |
3 |
0.0001 |
| 70 |
DRY EYE |
4 |
0.0001 |
| 71 |
ANOREXIA |
1 |
0.0001 |
| 72 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 73 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 74 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 75 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 76 |
FLUID OVERLOAD |
1 |
0.0001 |
| 77 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 78 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 79 |
MENINGIOMA |
1 |
0.0001 |
| 80 |
BRAIN FOG |
1 |
0.0001 |
| 81 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 82 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 83 |
LIP SWELLING |
2 |
0.0001 |
| 84 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 85 |
GASTRIC ULCER |
1 |
0.0001 |
| 86 |
DISABILITY |
1 |
0.0001 |
| 87 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 88 |
TREATMENT FAILURE |
4 |
0.0000 |
| 89 |
DERMATITIS |
1 |
0.0000 |
| 90 |
RETCHING |
1 |
0.0000 |
| 91 |
JOINT INJURY |
1 |
0.0000 |
| 92 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 93 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 94 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 95 |
ORAL PAIN |
1 |
0.0000 |
| 96 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 97 |
COMA |
2 |
0.0000 |
| 98 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 99 |
RASH GENERALISED |
1 |
0.0000 |
| 100 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 101 |
FEAR |
1 |
0.0000 |
| 102 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 103 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 104 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 105 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 106 |
MEDICATION ERROR |
2 |
0.0000 |
| 107 |
WOUND |
1 |
0.0000 |
| 108 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 109 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 110 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 111 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 112 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 113 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 114 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 115 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 116 |
EYE PRURITUS |
1 |
0.0000 |
| 117 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 118 |
ANGER |
1 |
0.0000 |
| 119 |
GASTRIC DISORDER |
1 |
0.0000 |
| 120 |
NIGHTMARE |
1 |
0.0000 |
| 121 |
HYPERKALAEMIA |
1 |
0.0000 |
| 122 |
HEART RATE DECREASED |
1 |
0.0000 |
| 123 |
RESTLESSNESS |
1 |
0.0000 |
| 124 |
COLITIS |
1 |
0.0000 |
| 125 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 126 |
SEPTIC SHOCK |
1 |
0.0000 |
| 127 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 128 |
VISION BLURRED |
3 |
0.0000 |
| 129 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 130 |
ARRHYTHMIA |
1 |
0.0000 |
| 131 |
RENAL CANCER |
1 |
0.0000 |
| 132 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 133 |
HEART RATE INCREASED |
2 |
0.0000 |
| 134 |
ECZEMA |
1 |
0.0000 |
| 135 |
HYPERTENSION |
4 |
0.0000 |
| 136 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 137 |
RASH PRURITIC |
1 |
0.0000 |
| 138 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 139 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 140 |
ARTHROPATHY |
1 |
0.0000 |
| 141 |
NECK PAIN |
1 |
0.0000 |
| 142 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 143 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 144 |
DYSPHONIA |
1 |
0.0000 |
| 145 |
PALPITATIONS |
2 |
0.0000 |
| 146 |
WHEEZING |
1 |
0.0000 |
| 147 |
CATARACT |
1 |
0.0000 |
| 148 |
DISCOMFORT |
1 |
0.0000 |
| 149 |
PSORIASIS |
2 |
0.0000 |
| 150 |
NAUSEA |
12 |
0.0000 |
| 151 |
RENAL FAILURE |
2 |
0.0000 |
| 152 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 153 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 154 |
BURNING SENSATION |
1 |
0.0000 |
| 155 |
INJURY |
1 |
0.0000 |
| 156 |
SLEEP DISORDER |
1 |
0.0000 |
| 157 |
DIZZINESS |
7 |
0.0000 |
| 158 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 159 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 160 |
CONSTIPATION |
3 |
0.0000 |
| 161 |
UNDERDOSE |
1 |
0.0000 |
| 162 |
HYPOAESTHESIA |
2 |
0.0000 |
| 163 |
ASTHENIA |
5 |
0.0000 |
| 164 |
HEADACHE |
8 |
0.0000 |
| 165 |
ARTHRITIS |
1 |
0.0000 |
| 166 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 167 |
FEELING ABNORMAL |
3 |
0.0000 |
| 168 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 169 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 170 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 171 |
CARDIAC ARREST |
1 |
0.0000 |
| 172 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 173 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 174 |
BALANCE DISORDER |
1 |
0.0000 |
| 175 |
FATIGUE |
9 |
0.0000 |
| 176 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 177 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 178 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 179 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 180 |
ANAEMIA |
2 |
0.0000 |
| 181 |
FLUSHING |
1 |
0.0000 |
| 182 |
SINUSITIS |
1 |
0.0000 |
| 183 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 184 |
DIARRHOEA |
6 |
0.0000 |
| 185 |
OVERDOSE |
2 |
0.0000 |
| 186 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 187 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 188 |
INSOMNIA |
2 |
0.0000 |
| 189 |
DEHYDRATION |
1 |
0.0000 |
| 190 |
NEUTROPENIA |
1 |
0.0000 |
| 191 |
INFECTION |
1 |
0.0000 |
| 192 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 193 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 194 |
PAIN |
4 |
0.0000 |
| 195 |
VOMITING |
3 |
0.0000 |
| 196 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 197 |
COVID-19 |
1 |
0.0000 |
| 198 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 199 |
MUSCLE SPASMS |
1 |
0.0000 |
| 200 |
CHEST PAIN |
1 |
0.0000 |
| 201 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 202 |
ALOPECIA |
1 |
0.0000 |
| 203 |
HYPOTENSION |
1 |
0.0000 |
| 204 |
SOMNOLENCE |
1 |
0.0000 |
| 205 |
WEIGHT INCREASED |
1 |
0.0000 |
| 206 |
DEPRESSION |
1 |
0.0000 |
| 207 |
DECREASED APPETITE |
1 |
0.0000 |
| 208 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 209 |
WEIGHT DECREASED |
1 |
0.0000 |
| 210 |
COUGH |
1 |
0.0000 |
| 211 |
ANXIETY |
1 |
0.0000 |
| 212 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 213 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 214 |
PNEUMONIA |
1 |
0.0000 |
| 215 |
FALL |
1 |
0.0000 |
| 216 |
PYREXIA |
1 |
0.0000 |
| 217 |
PRURITUS |
1 |
0.0000 |
| 218 |
ARTHRALGIA |
1 |
0.0000 |
| 219 |
RASH |
1 |
0.0000 |
| 220 |
OFF LABEL USE |
2 |
0.0000 |
| 221 |
MALAISE |
1 |
0.0000 |
| 222 |
DYSPNOEA |
1 |
0.0000 |
| 223 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 224 |
DEATH |
1 |
0.0000 |